Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)
Top Cited Papers
Open Access
- 19 June 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 1451
- https://doi.org/10.3389/fimmu.2020.01451
Abstract
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) represents an emergent global threat which is straining worldwide healthcare capacity. As of May 27th, the disease caused by SARS-CoV-2 (COVID-19) has resulted in more than 340,000 deaths worldwide, with 100,000 deaths in the US alone. It is imperative to study and develop pharmacological treatments suitable for the prevention and treatment of COVID-19. Ascorbic acid is a crucial vitamin necessary for the correct functioning of the immune system. It plays a role in stress response and has shown promising results when administered to the critically ill. Quercetin is a well-known flavonoid whose antiviral properties have been investigated in numerous studies. There is evidence that vitamin C and quercetin co-administration exerts a synergistic antiviral action due to overlapping antiviral and immunomodulatory properties and the capacity of ascorbate to recycle quercetin, increasing its efficacy. Safe, cheap interventions which have a sound biological rationale should be prioritized for experimental use in the current context of a global health pandemic. We present the current evidence for the use of vitamin C and quercetin both for prophylaxis in high-risk populations and for the treatment of COVID-19 patients as an adjunct to promising pharmacological agents such as Remdesivir or convalescent plasma.Keywords
This publication has 141 references indexed in Scilit:
- Influenza A Virus Entry Inhibitors Targeting the HemagglutininViruses, 2013
- Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-α/β at the Initial Stage of Influenza A Virus (H3N2) InfectionImmune Network, 2013
- Quercetin inhibits rhinovirus replication in vitro and in vivoAntiviral Research, 2012
- Antiviral activity of four types of bioflavonoid against dengue virus type-2Virology Journal, 2011
- Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expressionRespiratory Research, 2010
- Dietary flavonoid quercetin stimulates vasorelaxation in aortic vesselsFree Radical Biology & Medicine, 2010
- Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in ratsIndian Journal of Clinical Biochemistry, 2010
- Quercetin Blocks Airway Epithelial Cell Chemokine ExpressionAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Effect of treatment with certain flavonoids on Mengo virus-induced encephalitis in miceArchiv für die gesamte Virusforschung, 1978